本页面由Tiger Trade Technology Pte. Ltd.提供服务

Seres Therapeutics, Inc.

9.27
+0.41004.63%
盘后9.270.00000.00%18:50 EDT
成交量:7.69万
成交额:70.05万
市值:8,886.50万
市盈率:14.48
高:9.34
开:8.76
低:8.76
收:8.86
52周最高:29.98
52周最低:6.53
股本:958.63万
流通股本:729.26万
量比:2.14
换手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):0.6400
每股收益(LYR):0.0175
净资产收益率:19.64%
总资产收益率:-42.25%
市净率:2.01
市盈率(LYR):529.62

数据加载中...

2021/05/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/03/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

重要事件披露

8-K - Current report
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals